Share on StockTwits

Research analysts at Needham & Company LLC lifted their target price on shares of Cardiovascular Systems (NASDAQ:CSII) from $37.00 to $38.00 in a report released on Thursday. The firm currently has a “strong-buy” rating on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 33.80% from the company’s current price.

Cardiovascular Systems (NASDAQ:CSII) opened at 28.37 on Thursday. Cardiovascular Systems has a 52-week low of $18.83 and a 52-week high of $37.73. The stock has a 50-day moving average of $29.55 and a 200-day moving average of $30.49. The company’s market cap is $877.9 million.

Cardiovascular Systems (NASDAQ:CSII) last released its earnings data on Wednesday, August 6th. The company reported ($0.31) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.28) by $0.03. The company had revenue of $39.56 million for the quarter, compared to the consensus estimate of $37.21 million. Cardiovascular Systems’s revenue was up 37.3% compared to the same quarter last year. Analysts expect that Cardiovascular Systems will post $-1.21 EPS for the current fiscal year.

Separately, analysts at Bank of America initiated coverage on shares of Cardiovascular Systems in a research note on Monday, May 12th. They set a “buy” rating and a $38.00 price target on the stock. One research analyst has rated the stock with a hold rating, four have given a buy rating and two have issued a strong buy rating to the company. Cardiovascular Systems currently has an average rating of “Buy” and a consensus target price of $39.54.

Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.